EMA Authorised: Tecfidera (dimethyl fumarate) — Biogen Netherlands B.V.

View source ↗

Summary

Authorisation of Tecfidera (dimethyl fumarate) in the European Union for the treatment of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Tecfidera (dimethyl fumarate)

Snippet

Status: Authorised. Therapeutic area: Multiple Sclerosis. MAH: Biogen Netherlands B.V.. Decision date: 09/07/2026